The results were good, the stuff works, it kills staph, and is safe. As stated previously trial participants were not given chlorhexidine baths like other bactroban/mupiricin trials. That means there was a higher chance of recolonisation from parts of the body where staph was still active.
Also, there were not enough participants with MRSA to include it in the results. The 2b trial will sample a larger group.
BOT - Anything but charting, page-1878
-
- There are more pages in this discussion • 8,941 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.784M | 4.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248028 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 356327 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |